IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies

Go back to IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
(NASDAQ: INAB) Delayed: 1.43 --0 (-0%)
Previous Close $1.43    52 Week High
Open $1.43    52 Week Low
Day High $1.43    P/E N/A 
Day Low $1.43    EPS
Volume 311